Preconception predictors of adverse pregnancy outcomes among women with SLE include previous lupus nephritis, chronic hypertension, SLE disease activity, and APS.

A study found that switching from rituximab to biosimilar CT-P10 is safe and effective for patients with systemic lupus ...

The following is a summary of “Association Between Novel Antiphospholipid Antibodies and Adverse Pregnancy Outcomes,” published in the September 2024 issue of Obstetrics and Gynecology by Moyle et al.

The following is a summary of “Coronary Artery Calcification Progression in Patients With Systemic Lupus Erythematosus,” ...

先看病例患者女，69 岁，2014 年因甲状腺癌入院手术，切除甲状腺及甲状旁腺，术后病理腺癌，未行放疗、化疗等其他辅助治疗，口服甲状腺素片替代治疗及钙维生素 D 片+ 阿法骨化醇胶丸。2016 年 1 月体检 CEA 轻度升高；2016 年 4 月 ...

In the Phase III REGENCY study, Gazyva elicited superior complete renal response rates in patients with lupus nephritis ...

UCB and Biogen’s drug dapirolizumab pegol has met the primary endpoint of improvement in disease activity in lupus patients.

With a drug in advanced testing for two different indications that have spawned several blockbuster drugs, could Alumis be ...

A 40-year-old man presented to the emergency department with a 5-day history of fevers, sore throat, fatigue, subjective ...

ONE year after being diagnosed with lupus at 21 and initially fearing that it meant an early end to her life, ‘lupus warrior’ ...

Roche announces positive results from phase III study of Gazyva/Gazyvaro in people with lupus nephritis: Basel Friday, September 27, 2024, 12:00 Hrs [IST] Roche announced positive ...

Diagnosed with a severe and painful form of juvenile arthritis triggered by sunlight, Ysabella has adapted to life indoors.